arrow-positive PFE - Pfizer Inc. 25.62 -0.42 (-1.61%)

As of June 8, 2026 4:02 pm EDT
Add to Watchlist
Get new quote

Quote Detail

Last 25.62
Change -0.42
Change % -1.61
Bid 25.65 X 1200
Ask 25.67 X 1800
Volume 42.03 M
Shares 5.7 B
Market Cap 148.41 B
   
Open 25.97
High 26.22
Low 25.60
Prev Close 26.04
52 Wk High 28.75
52 Wk Low 23.11
EPS 1.3128
P/E 19.96
Div Yield 6.71

Market Headlines

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines 05/28/2026 07:01PM

SAN FRANCISCO and NEW YORK, and SUZHOU, China, May 28, 2026 /PRNewswire via COMTEX News Network/ -- Innovent Biologics, Inc. (01801.HK) and Pfizer Inc. (NYSE: PFE), today announced the companies...

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines 05/28/2026 06:59PM

SAN FRANCISCO and NEW YORK, and SUZHOU, China, May 28, 2026 /PRNewswire via COMTEX News Network/ -- Innovent Biologics, Inc. (01801.HK) and Pfizer Inc. (NYSE: PFE), today announced the companies...

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer 05/17/2026 07:09PM

Mar 19, 2026 (MarketLine via COMTEX News Network) -- Pfizer reported positive topline Phase 3 TALAPRO-3 results showing that TALZENNA (talazoparib) in combination with XTANDI (enzalutamide)...

BioMedNewsBreaks -- SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly 05/11/2026 10:14AM

May 11, 2026 (Investor Brand Network via COMTEX News Network) -- This article has been disseminated on behalf of SureNano Science Ltd. and may include paid advertising.